The pharmacoepidemiology of COPD: recent advances and methodological discussion

P Burney, S Suissa, J B Soriano, W M Vollmer, G Viegi, S D Sullivan, L M Fabbri, D D Sin, P Ernst, D Coultas, J Bourbeau, D W Mapel, K Weiss, T McLaughlin, David Brendan Price, M C J M Sturkenboom, R Taylor, G W Hagan

Research output: Contribution to journalArticlepeer-review

39 Citations (Scopus)
Original languageEnglish
Pages (from-to)1s-44s
Number of pages44
JournalEuropean Respiratory Journal
Volume43
Publication statusPublished - 1 Sep 2003

Keywords

  • Age Distribution
  • Aged
  • Aged, 80 and over
  • Cost-Benefit Analysis
  • Europe
  • Female
  • Forecasting
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Pharmacoepidemiology
  • Pulmonary Disease, Chronic Obstructive
  • Quality of Life
  • Respiratory Function Tests
  • Risk Assessment
  • Severity of Illness Index
  • Sex Distribution
  • Survival Analysis
  • United States

Cite this